| Dr Crystal A Comeau, MD | |
|
35 Collier Rd Nw, Suite 635, Atlanta, GA 30309-1613 | |
| (404) 367-3014 | |
| (404) 367-3558 |
| Full Name | Dr Crystal A Comeau |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 35 Collier Rd Nw, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578570644 | NPI | - | NPPES |
| 264862800 | Medicaid | FL | |
| 116071235A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 61224 (Georgia) | Primary |
| 207Q00000X | Family Medicine | 061224 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Northwest Home Health | Jasper, GA | Home health agency |
| Hospice Advantage, Llc | Ellijay, GA | Hospice |
| Piedmont Mountainside Hospital Inc | Jasper, GA | Hospital |
| Parkside Center For Nursing And Rehab At Ellijay | Ellijay, GA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Hospitalist Physicians Llc | 1951299163 | 303 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.
The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.
Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.
Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.
› Verified 4 days ago
| Entity Name | Piedmont Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548219660 PECOS PAC ID: 1951299163 Enrollment ID: O20040309000820 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.
The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.
Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.
Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.
› Verified 4 days ago
| Entity Name | Northside Urgent Care Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679962237 PECOS PAC ID: 4587984695 Enrollment ID: O20150513000795 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.
The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.
Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.
Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.
› Verified 4 days ago
| Entity Name | Post Acute Care Leaders Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033689336 PECOS PAC ID: 4082951546 Enrollment ID: O20190123000710 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.
The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.
Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.
Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Crystal A Comeau, MD 35 Collier Rd Nw, Suite 635, Atlanta, GA 30309-1613 Ph: (404) 367-3014 | Dr Crystal A Comeau, MD 35 Collier Rd Nw, Suite 635, Atlanta, GA 30309-1613 Ph: (404) 367-3014 |
News Archive
BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.
Solar radiation in Spain has increased by 2.3% every decade since the 1980s, according to a study by researchers from the University of Girona and the Federal Institute of Technology (ETH) in Zurich. This increase is linked to the decreased presence of clouds, which has increased the amount of direct radiation reaching us from the Sun.
The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.
Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.
Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.
› Verified 4 days ago
Dr. Tianna E. Johnson, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 35 Collier Rd Nw, Suite 635, Atlanta, GA 30309 Phone: 404-367-3014 Fax: 404-367-3558 | |
Dr. Maha Osman Sulieman, MBBS Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-712-2000 | |
Sarah Latif, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 35 Collier Rd Nw Ste 635, Atlanta, GA 30309 Phone: 404-367-3014 | |
Dr. Tait Thomas Jones, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1362 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-727-5658 | |
Candice Marie Delk, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 35 Collier Rd Nw, Suite 635, Atlanta, GA 30309 Phone: 404-367-3014 Fax: 404-367-3558 | |
Thara Mrithula Vidyasagaran, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-712-7100 | |
Matthew Jason Brown, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 49 Jesse Hill Jr Dr Se, Atlanta, GA 30303 Phone: 404-778-7777 |